J. Gibson

发表

Infusion thrombophlebitis and infiltration associated with intravenous cannulae: a controlled study comparing three different cannula types.

D. N. Williams, A. C. Kind, J. Gibson, 1982, NITA.

Cutaneous infection with Mycobacterium abscessus

J. Gibson, D. A. Fitzgerald, A. Smith, 1995, The British journal of dermatology.

A double‐blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis

J. Mansfield, J. Green, G. Kerr, 2002, Alimentary pharmacology & therapeutics.

Intravenous antibiotic therapy at home.

D. N. Williams, A. C. Kind, J. Gibson, 1979, Archives of internal medicine.

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group.

A. Lobo, R. Leicester, C. Holdsworth, 1998, Gastroenterology.

Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months

A. Rowlinson, E. Swarbrick, J. Green, 1992, Alimentary pharmacology & therapeutics.

Home intravenous antibiotic therapy using a programmable infusion pump.

J. Gibson, D. Bosch, D. Williams, 1989, Archives of internal medicine.

Outpatient intravenous antibiotic therapy. Ten years' experience.

A. C. Kind, J. Gibson, D. Williams, 1985, Postgraduate medicine.

Outpatient intravenous antibiotic therapy.

A. C. Kind, D. Williams, J. Gibson, 1984, The Journal of antimicrobial chemotherapy.

Comparison of twice-daily ranitidine and placebo in the treatment of duodenal ulcer--a multicentre study in the United Kingdom.

G. Holmes, W. Stone, K. Hine, 1982, Hepato-gastroenterology.

Ranitidine: prophylaxis of duodenal ulcer recurrence.

G. Holmes, K. Hine, F. I. Lee, 1984, Hepato-gastroenterology.

Patient‐led variable dosing with balsalazide as long‐term therapy for maintenance in ulcerative colitis: a 3‐year prospective observational study

E. Swarbrick, J. Green, G. Kerr, 2004, Alimentary pharmacology & therapeutics.